First Horizon Advisors, Inc. Repligen Corp Transaction History

First Horizon Advisors, Inc.

  • $3.58 Billion
  • Q3 2024

A detailed history of First Horizon Advisors, Inc. transactions in Repligen Corp stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 740 shares of RGEN stock, worth $105,398. This represents 0.0% of its overall portfolio holdings.

Number of Shares
740
Previous 701 5.56%
Holding current value
$105,398
Previous $88,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$119.79 - $167.35 $4,671 - $6,526
39 Added 5.56%
740 $110,000
Q2 2024

Jul 19, 2024
BUY
$120.0 - $182.95 $9,000 - $13,721
75 Added 11.98%
701 $88,000
Q1 2024

Apr 26, 2024
SELL
$170.78 - $208.42 $4,269 - $5,210
-25 Reduced 3.84%
626 $115,000
Q4 2023

Feb 06, 2024
SELL
$114.17 - $185.35 $2,740 - $4,448
-24 Reduced 3.56%
651 $117,000
Q3 2023

Oct 27, 2023
BUY
$138.78 - $176.51 $12,073 - $15,356
87 Added 14.8%
675 $107,000
Q2 2023

Aug 03, 2023
BUY
$138.42 - $180.31 $692 - $901
5 Added 0.86%
588 $83,000
Q1 2023

May 15, 2023
SELL
$154.26 - $198.1 $16,660 - $21,394
-108 Reduced 15.63%
583 $98,000
Q4 2022

Feb 10, 2023
BUY
$162.42 - $220.56 $4,872 - $6,616
30 Added 4.54%
691 $116,000
Q3 2022

Nov 09, 2022
SELL
$160.42 - $256.21 $18,127 - $28,951
-113 Reduced 14.6%
661 $123,000
Q2 2022

Aug 02, 2022
BUY
$140.68 - $188.02 $103,540 - $138,382
736 Added 1936.84%
774 $125,000
Q1 2022

May 10, 2022
SELL
$161.19 - $257.96 $107,352 - $171,801
-666 Reduced 94.6%
38 $7,000
Q4 2021

Feb 09, 2022
BUY
$247.59 - $304.47 $11,389 - $14,005
46 Added 6.99%
704 $186,000
Q3 2021

Nov 15, 2021
SELL
$194.77 - $324.21 $80,634 - $134,222
-414 Reduced 38.62%
658 $190,000
Q3 2021

Nov 09, 2021
BUY
$194.77 - $324.21 $136,144 - $226,622
699 Added 187.4%
1,072 $309,000
Q2 2021

Aug 09, 2021
BUY
$165.87 - $220.95 $331 - $441
2 Added 0.54%
373 $74,000
Q1 2021

May 11, 2021
SELL
$180.37 - $226.26 $3,066 - $3,846
-17 Reduced 4.38%
371 $72,000
Q4 2020

Feb 11, 2021
BUY
$148.08 - $206.57 $2,961 - $4,131
20 Added 5.43%
388 $74,000
Q3 2020

Nov 12, 2020
SELL
$122.51 - $158.27 $6,248 - $8,071
-51 Reduced 12.17%
368 $54,000
Q2 2020

Jul 31, 2020
BUY
$94.33 - $140.48 $18,488 - $27,534
196 Added 87.89%
419 $51,000
Q1 2020

May 05, 2020
BUY
$84.96 - $109.14 $11,214 - $14,406
132 Added 145.05%
223 $21,000
Q3 2019

Oct 23, 2019
BUY
$76.65 - $95.51 $6,975 - $8,691
91 New
91 $6,000

Others Institutions Holding RGEN

# of Institutions
488
Shares Held
54.3M
Call Options Held
350K
Put Options Held
184K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.9B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email